• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Opinion

Video

Telehealth and Research Strides for Young Patients

Key Takeaways

  • Telemedicine and digital health tools enable remote consultations, improving management and follow-up care for pediatric vitiligo patients by reducing the need for frequent in-person visits.
  • Emerging research aims to understand vitiligo pathogenesis, focusing on immune modulation, genetic factors, and novel drug targets to develop therapies that halt or slow disease progression.
SHOW MORE

Lisa Swanson, MD, discusses how telemedicine and digital health tools can aid in the management and follow-up care of pediatric patients with vitiligo by enabling remote monitoring, improving access to specialists, and facilitating patient engagement, while emerging research into vitiligo treatments may focus on developing therapies to halt or slow the progression of this autoimmune skin condition.

Video content above is prompted by the following:

  • How do you see advancements in telemedicine or digital health tools aiding in the management and follow-up care of pediatric vitiligo patients?
  • In terms of future treatments, what emerging research might focus on halting or slowing the progression of the disease?
Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
3 experts are featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.